Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials
Conclusion: Ticagrelor increased the risk of bleeding and did not increase treatment efficacy compared to that of clopidogrel in the East Asian population who have ACS treated with PCI.
Source: Cardiology - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Bleeding | Cardiology | Cardiovascular | China Health | Clinical Trials | Clopidogrel | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Science | Statistics | Stroke | Thrombosis